Rankings
▼
Calendar
ALKS Q3 2022 Earnings — Alkermes plc Revenue & Financial Results | Market Cap Arena
ALKS
Alkermes plc
$5B
Q3 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$252M
-14.2% YoY
Gross Profit
$202M
79.9% margin
Operating Income
-$61M
-24.0% margin
Net Income
-$64M
-25.4% margin
EPS (Diluted)
$-0.39
QoQ Revenue Growth
-8.6%
Cash Flow
Operating Cash Flow
$625,000
Free Cash Flow
-$10M
Stock-Based Comp.
$26M
Balance Sheet
Total Assets
$1.9B
Total Liabilities
$899M
Stockholders' Equity
$1.0B
Cash & Equivalents
$264M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$252M
$294M
-14.2%
Gross Profit
$202M
$245M
-17.5%
Operating Income
-$61M
-$20M
-208.5%
Net Income
-$64M
-$29M
-120.7%
Revenue Segments
Manufacturing Revenue
$17M
100%
← FY 2022
All Quarters
Q4 2022 →